Styramate: Difference between revisions
No edit summary |
m (Protected "Styramate": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
(No difference)
|
Latest revision as of 17:11, 20 August 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C9H11NO3 |
Molar mass | 181.189 g/mol |
3D model (JSmol) | |
| |
(verify) |
WikiDoc Resources for Styramate |
Articles |
---|
Most recent articles on Styramate |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Styramate at Clinical Trials.gov Clinical Trials on Styramate at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Styramate
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Styramate Discussion groups on Styramate Directions to Hospitals Treating Styramate Risk calculators and risk factors for Styramate
|
Healthcare Provider Resources |
Causes & Risk Factors for Styramate |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Styramate is a muscle relaxant and anticonvulsant drug. At therapeutic doses, it does not produce significant sedative effects.
See also
External links
- S De Salva, R Evans. (1960). "Anticonvulsive character of styramate and other depressant drugs". Toxicology and Applied Pharmacology. 2 (4): 397–402. doi:10.1016/0041-008X(60)90006-5. PMID 13815010.
- B.W. Billow, F.J. Martorella, S.S. Paley. (Jan 1960). "Clinical experiences with styramate, a nonsedative skeletal muscle relaxant". Int Rec Med. 173: 35–38. PMID 13800722.